MECP2 and Apnea: The study was designed based on data extracted from mouse models (MeCP2 null male and heterozygous females, one with a common nonsense mutation (R168X), and the other with deletions in exon 3 and 4), being observed a decrease in apnea incidence of 25–33% [121].